PHST (6.30):Big board move should open doors, IMO.
Moved up to Nasdaq last week (following a 1 for 3 R/S) and will finally get the attention it's deserved for a couple of years, IMO.
Pharsight Common Stock to Begin Trading on Nasdaq Capital Market Today
MOUNTAIN VIEW, Calif., Nov. 27 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, announced today that its common stock will trade on the Nasdaq Capital Market under the symbol 'PHST,' starting at the opening of market today, November 27, 2007. The stock previously traded on the OTC Bulletin Board under the symbol (OTC Bulletin Board: PHRS).
About Pharsight Corporation
Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.
Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com.
SOURCE Pharsight Corporation
Source: PR Newswire (November 27, 2007 - 6:30 AM EST)
News by QuoteMedia
www.quotemedia.com
Moved up to Nasdaq last week (following a 1 for 3 R/S) and will finally get the attention it's deserved for a couple of years, IMO.
Pharsight Common Stock to Begin Trading on Nasdaq Capital Market Today
MOUNTAIN VIEW, Calif., Nov. 27 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, announced today that its common stock will trade on the Nasdaq Capital Market under the symbol 'PHST,' starting at the opening of market today, November 27, 2007. The stock previously traded on the OTC Bulletin Board under the symbol (OTC Bulletin Board: PHRS).
About Pharsight Corporation
Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.
Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com.
SOURCE Pharsight Corporation
Source: PR Newswire (November 27, 2007 - 6:30 AM EST)
News by QuoteMedia
www.quotemedia.com
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
